Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 5,725 $ 148,888,635 $ (121,370,240) $ 27,524,120
Balance, shares at Dec. 31, 2018 57,247,496      
Issuance of common stock, net of issuance costs $ 620 37,718,078 37,718,698
Issuance of common stock, net of issuance costs, shares 6,198,500      
Stock compensation expense 3,088,939 3,088,939
Issuance of common stock upon exercise of stock options $ 6 203,997 204,003
Issuance of common stock upon exercise of stock options, shares 61,771      
Issuance of common stock upon exercise of warrants $ 95 (95)
Issuance of common stock upon exercise of warrants, shares 947,454      
Net loss (26,234,809) (26,234,809)
Balance at Mar. 31, 2019 $ 6,446 189,899,554 (147,605,049) 42,300,951
Balance, shares at Mar. 31, 2019 64,455,221      
Balance at Dec. 31, 2019 $ 6,467 198,975,056 (192,823,958) 6,157,565
Balance, shares at Dec. 31, 2019 64,672,893      
Issuance of common stock, net of issuance costs $ 767 43,036,445 43,037,212
Issuance of common stock, net of issuance costs, shares 7,666,667      
Stock compensation expense 3,137,519 3,137,519
Issuance of common stock upon exercise of stock options $ 15 15,979 $ 15,994
Issuance of common stock upon exercise of stock options, shares 150,889     150,889
Net loss (29,656,800) $ (29,656,800)
Balance at Mar. 31, 2020 $ 7,249 $ 245,164,999 $ (222,480,758) $ 22,691,490
Balance, shares at Mar. 31, 2020 72,490,449